FAQs
What is the main focus of the Associate Director, Supply Chain Logistics role?
The main focus is to build and oversee cell therapy supply capabilities in the EU and UK for AstraZeneca's cell therapy products across the global supply chain.
Who will the Associate Director report to?
The Associate Director will report to the Senior Director of Cell Therapy Global Logistics.
What kind of experience is required for this position?
A minimum of ten (10) years of experience with a Bachelor's degree, or eight (8) years with a Master's degree/MBA, along with experience in cell therapy supply chain logistics and warehousing/logistics, particularly with temperature-controlled storage.
What are the responsibilities regarding patient scheduling?
The Associate Director will create patient scheduling processes for apheresis, manufacturing, and return of drug product to clinical sites.
Will the role involve collaboration with other teams?
Yes, the role involves collaboration with Clinical and Quality teams to prepare clinical sites for AstraZeneca's cell therapy trials.
Is there an opportunity for team development?
Yes, the Associate Director will have the responsibility to build a growing team to manage the supply of cell therapy products in the EU and UK.
What logistical tasks will be overseen in this role?
The role will involve overseeing logistics of Apheresis and Drug Product shipments, adapting Chain of Identity (COI) and Chain of Custody (COC) processes, and setting up GMP operations at the EU and UK logistics depot.
What kind of work environment does AstraZeneca promote for this role?
AstraZeneca promotes a collaborative and inclusive environment with colleagues from diverse backgrounds, supporting hybrid working with three days in the office.
Are there additional benefits offered beyond a competitive salary?
Yes, in addition to a competitive salary, benefits include an attractive bonus scheme, access to internal training and development programs, and a pension plan.
What is the main impact of this position on patients?
The work directly contributes to enhancing the quality of life and increasing the life expectancy of people with severe chronic illnesses through the development of innovative medicines.